Evidence map›Paper›PMID 22815131›Full record

ReviewCurrent allergy and asthma reports2012

Anaphylaxis in children: current understanding and key issues in diagnosis and treatment.

Chitra Dinakar

Open access · hybridAbstract readReview
In one paragraph

Review in Current allergy and asthma reports, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. Comment on "Ensuring the Efficacy and Safety of Approved Medications ".Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2024
    Article
  4. Development ofPharmaceutics · 2024
    Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Drug-induced anaphylaxis in children.Acta bio-medica : Atenei Parmensis · 2019
    Review
  13. Article
  14. The Epidemiology of Anaphylaxis.Clinical reviews in allergy & immunology · 2018
    Review
  15. Review
  16. Anaphylaxis secondary toBMJ case reports · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Chitra DinakarSection of Allergy, Asthma and Immunology, Children's Mercy Hospital and Clinics, University of Missouri-Kansas City, Kansas City, MO 64108, USA. cdinakar@cmh.edu
Children's Mercy Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anaphylaxis is a severe allergic reaction that is rapid in onset and may cause death. Since it is unpredictable and potentially fatal, prompt recognition and treatment are vital to maximize a positive outcome. The occurrence of anaphylaxis is increasing across all ages in the United States, with increased risk of worse outcome in teenagers/young adults and in those with comorbid conditions such as asthma. Gaps in the assessment of patient-specific risk factors, identification and prevention of triggers, recognition of signs/symptoms, and pharmacologic treatment of anaphylaxis have been identified at the physician and caregiver/patient level. A PubMed literature search (January 2000-December 2011) was conducted to identify publications on childhood anaphylaxis using the following terms: food allergy, food allergens, food hypersensitivity, epinephrine, epinephrine auto-injectors, anaphylactic triggers, and anaphylaxis. This review will critically appraise these key issues and highlight strategies that might result in improved management of anaphylaxis in children.

Indexed as

Age DistributionAnaphylaxisAsthmaCausalityChildChild, PreschoolComorbidityEpinephrineFood HypersensitivityHumansInfantInfant, NewbornRisk FactorsEpinephrine

Identifiers

PMID22815131
PMCPMC3492692
OpenAlexW2001847168

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.